{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:40:19Z","timestamp":1793209219094,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217786","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:23:12Z","timestamp":1746757392000},"page":"217786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting of COP\u2160 elicits CD8+ T cell-mediated anti-tumor immunity and suppresses growth of intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"626","author":[{"given":"Zehong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5451-1282","authenticated-orcid":false,"given":"Zhaojuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lvzhu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningqian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1477-116X","authenticated-orcid":false,"given":"Yongzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9835-7846","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217786_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2025.217786_bib2","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/1078-0432.CCR-21-1157","article-title":"Multiomic analysis reveals comprehensive tumor heterogeneity and distinct immune subtypes in multifocal intrahepatic cholangiocarcinoma","volume":"28","author":"Chen","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217786_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13046-022-02340-2","article-title":"The role of tumor-infiltrating lymphocytes in cholangiocarcinoma","volume":"41","author":"Liu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217786_bib4","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ejso.2019.04.019","article-title":"The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma","volume":"45","author":"Lurje","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2025.217786_bib5","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/gutjnl-2021-324109","article-title":"GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity","volume":"71","author":"Ruffolo","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2025.217786_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-024-07121-9","article-title":"Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T(reg) cells","volume":"627","author":"Guan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217786_bib7","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cell.2023.02.039","article-title":"Advances in cancer immunotherapies","volume":"186","author":"Dagher","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217786_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-biophys-070317-033259","article-title":"Assembly of COPI and COPII vesicular coat proteins on membranes","volume":"47","author":"Bethune","year":"2018","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.canlet.2025.217786_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.3279","article-title":"COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis","volume":"47","author":"Watkin","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2025.217786_bib10","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1111\/jcmm.14398","article-title":"COPB2 is up-regulated in breast cancer and plays a vital role in the metastasis via N-cadherin and Vimentin","volume":"23","author":"Bhandari","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2025.217786_bib11","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1080\/09168451.2020.1783197","article-title":"MiR-216a-3p regulates the proliferation, apoptosis, migration, and invasion of lung cancer cells via targeting COPB2","volume":"84","author":"Wang","year":"2020","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.canlet.2025.217786_bib12","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/s41556-023-01287-6","article-title":"COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells","volume":"25","author":"McHugh","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217786_bib13","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41467-023-42150-4","article-title":"ARF1 prevents aberrant type I interferon induction by regulating STING activation and recycling","volume":"14","author":"Hirschenberger","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217786_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201045","article-title":"A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome","volume":"217","author":"Deng","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2025.217786_bib15","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","article-title":"The cGAS-STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2025.217786_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217786_bib17","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4049\/jimmunol.1900387","article-title":"YIPF5 is essential for innate immunity to DNA virus and facilitates COPII-dependent STING trafficking","volume":"203","author":"Ran","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2025.217786_bib18","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1038\/s41467-022-29946-6","article-title":"Deficiency in coatomer complex I causes aberrant activation of STING signalling","volume":"13","author":"Steiner","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217786_bib19","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200600","article-title":"Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling","volume":"217","author":"Lepelley","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2025.217786_bib20","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1021\/acs.biochem.7b00706","article-title":"Family-wide analysis of the inhibition of Arf guanine nucleotide exchange factors with small molecules: evidence of unique inhibitory profiles","volume":"56","author":"Benabdi","year":"2017","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.canlet.2025.217786_bib21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/HEP.0000000000000711","article-title":"UBXN9 inhibits the RNA exosome function to promote T cell control of liver tumorigenesis","volume":"80","author":"Zhang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2025.217786_bib22","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"Beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"issue":"65","key":"10.1016\/j.canlet.2025.217786_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc6424","article-title":"Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape","volume":"6","author":"Takeuchi","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.canlet.2025.217786_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.immuni.2022.03.007","article-title":"The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade","volume":"55","author":"Cucolo","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2025.217786_bib25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217786_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217786_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41574-022-00737-9","article-title":"Endosomal trafficking in metabolic homeostasis and diseases","volume":"19","author":"Gilleron","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.canlet.2025.217786_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216992","article-title":"Stage-specificity of STING activation in intrahepatic cholangiocarcinoma determines the efficacy of its agonism","volume":"594","author":"Luo","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217786_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING agonist MIW815 (ADU-S100) and PD-1 inhibitor spartalizumab in advanced\/metastatic solid tumors or lymphomas: an open-label, multicenter, phase Ib study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.217786_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.102992","article-title":"The small molecule inhibitor NAV-2729 has a complex target profile including multiple ADP-ribosylation factor regulatory proteins","volume":"299","author":"Rosenberg","year":"2023","journal-title":"J. Biol. Chem."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:01:04Z","timestamp":1760742064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"alternative-id":["S0304383525003520"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217786","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting of COP\u2160 elicits CD8+ T cell-mediated anti-tumor immunity and suppresses growth of intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217786"}}